Moreover, a transient overexpression of IFNL4 in hepatoma cells in vitro stimulated the expression of ISGs [21], which is consistent with the observation of a high baseline activation of ISGs in poor treatment responders. Here, IFNL4 is linked to hepatocellular carcinoma.